This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watts, G. S.
Right arrow Articles by Futscher, B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watts, G. S.
Right arrow Articles by Futscher, B. W.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Sep 1997, 5612-5619, Vol 17, No. 9
Copyright © 1997, American Society for Microbiology

Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene

GS Watts, RO Pieper, JF Costello, YM Peng, WS Dalton and BW Futscher
Bone Marrow Transplant Program, Arizona Cancer Center, and Department of Pharmacology, University of Arizona, Tucson 85724, USA.

O6-Methylguanine DNA methyltransferase (MGMT) repairs the mutagenic and cytotoxic O6-alkylguanine lesions produced by environmental carcinogens and the chemotherapeutic nitrosoureas. As such, MGMT-mediated repair of O6-alkylguanine lesions constitutes a major form of resistance to nitrosourea chemotherapy and makes control of MGMT expression of clinical interest. The variability of expression in cell lines and tissues, along with the ease with which the MGMT phenotype reverts under various conditions, suggests that MGMT is under epigenetic control. One such epigenetic mechanism, 5-methylation of cytosines, has been linked to MGMT expression. We have used an isogenic human multiple myeloma tumor cell line model composed of an MGMT-positive parent cell line, RPMI 8226/S, and its MGMT-negative variant, termed 8226/V, to study the control of MGMT expression. The loss of MGMT activity in 8226/V was found to be due to the loss of detectable MGMT gene expression. Bisulfite sequencing of the MGMT CpG island promoter revealed large increases in the levels of CpG methylation within discrete regions of the 8226/V MGMT CpG island compared to those in 8226/S. These changes in CpG methylation are associated with local heterochromatinization of the 8226/V MGMT transcription start site and provide a likely mechanism for the loss of MGMT transcription in 8226/V.


This article has been cited by other articles:

  • Wick, W., Platten, M., Weller, M. (2009). New (alternative) temozolomide regimens for the treatment of glioma. Neuro Oncol Duke 11: 69-79 [Abstract] [Full Text]  
  • Everhard, S., Tost, J., El Abdalaoui, H., Criniere, E., Busato, F., Marie, Y., Gut, I. G., Sanson, M., Mokhtari, K., Laigle-Donadey, F., Hoang-Xuan, K., Delattre, J.-Y., Thillet, J. (2009). Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. Neuro Oncol Duke 11: 348-356 [Abstract] [Full Text]  
  • Hegi, M. E., Liu, L., Herman, J. G., Stupp, R., Wick, W., Weller, M., Mehta, M. P., Gilbert, M. R. (2008). Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity. JCO 26: 4189-4199 [Abstract] [Full Text]  
  • Ma, L.-C., Kuo, C.-C., Liu, J.-F., Chen, L.-T., Chang, J.-Y. (2008). Transcriptional Repression of O6-Methylguanine DNA Methyltransferase Gene Rendering Cells Hypersensitive to N,N'-Bis(2-chloroethyl)-N-nitrosurea in Camptothecin-Resistant Cells. Mol. Pharmacol. 74: 517-526 [Abstract] [Full Text]  
  • Vlassenbroeck, I., Califice, S., Diserens, A.-C., Migliavacca, E., Straub, J., Di Stefano, I., Moreau, F., Hamou, M.-F., Renard, I., Delorenzi, M., Flamion, B., DiGuiseppi, J., Bierau, K., Hegi, M. E. (2008). Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma. J. Mol. Diagn. 10: 332-337 [Abstract] [Full Text]  
  • Lavon, I., Fuchs, D., Zrihan, D., Efroni, G., Zelikovitch, B., Fellig, Y., Siegal, T. (2007). Novel Mechanism whereby Nuclear Factor {kappa}B Mediates DNA Damage Repair through Regulation of O6-Methylguanine-DNA-Methyltransferase. Cancer Res. 67: 8952-8959 [Abstract] [Full Text]  
  • Ohgaki, H., Kleihues, P. (2007). Genetic Pathways to Primary and Secondary Glioblastoma. Am. J. Pathol. 170: 1445-1453 [Abstract] [Full Text]  
  • Reardon, D. A., Rich, J. N., Friedman, H. S., Bigner, D. D. (2006). Recent Advances in the Treatment of Malignant Astrocytoma. JCO 24: 1253-1265 [Abstract] [Full Text]  
  • McCabe, M. T., Low, J. A., Daignault, S., Imperiale, M. J., Wojno, K. J., Day, M. L. (2006). Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer. Cancer Res. 66: 385-392 [Abstract] [Full Text]  
  • Halford, S, Rowan, A, Sawyer, E, Talbot, I, Tomlinson, I (2005). O6-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions. Gut 54: 797-802 [Abstract] [Full Text]  
  • Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., Bromberg, J. E.C., Hau, P., Mirimanoff, R. O., Cairncross, J. G., Janzer, R. C., Stupp, R. (2005). MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma. NEJM 352: 997-1003 [Abstract] [Full Text]  
  • Danam, R. P., Howell, S. R., Brent, T. P., Harris, L. C. (2005). Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Molecular Cancer Therapeutics 4: 61-69 [Abstract] [Full Text]  
  • Paz, M. F., Yaya-Tur, R., Rojas-Marcos, I., Reynes, G., Pollan, M., Aguirre-Cruz, L., Garcia-Lopez, J. L., Piquer, J., Safont, M.-J., Balana, C., Sanchez-Cespedes, M., Garcia-Villanueva, M., Arribas, L., Esteller, M. (2004). CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas. Clin. Cancer Res. 10: 4933-4938 [Abstract] [Full Text]  
  • Rood, B. R., Zhang, H., Cogen, P. H. (2004). Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma. Neuro Oncol Duke 6: 200-207 [Abstract]  
  • Domann, F. E., Futscher, B. W. (2004). Flipping the Epigenetic Switch. Am. J. Pathol. 164: 1883-1886 [Full Text]  
  • Goldenberg, D., Harden, S., Masayesva, B. G., Ha, P., Benoit, N., Westra, W. H., Koch, W. M., Sidransky, D., Califano, J. A. (2004). Intraoperative Molecular Margin Analysis in Head and Neck Cancer. Arch Otolaryngol Head Neck Surg 130: 39-44 [Abstract] [Full Text]  
  • Zhang, L., Lu, W., Miao, X., Xing, D., Tan, W., Lin, D. (2003). Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma. Carcinogenesis 24: 1039-1044 [Abstract] [Full Text]  
  • Danesi, R., De Braud, F., Fogli, S., De Pas, T. M., Di Paolo, A., Curigliano, G., Del Tacca, M. (2003). Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer. Pharmacol. Rev. 55: 57-103 [Abstract] [Full Text]  
  • Brabender, J., Usadel, H., Metzger, R., Schneider, P. M., Park, J., Salonga, D., Tsao-Wei, D. D., Groshen, S., Lord, R. V., Takebe, N., Schneider, S., Holscher, A. H., Danenberg, K. D., Danenberg, P. V. (2003). Quantitative O6-Methylguanine DNA Methyltransferase Methylation Analysis in Curatively Resected Non-Small Cell Lung Cancer: Associations with Clinical Outcome. Clin. Cancer Res. 9: 223-227 [Abstract] [Full Text]  
  • Esteller, M., Gaidano, G., Goodman, S. N., Zagonel, V., Capello, D., Botto, B., Rossi, D., Gloghini, A., Vitolo, U., Carbone, A., Baylin, S. B., Herman, J. G. (2002). Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma. JNCI J Natl Cancer Inst 94: 26-32 [Abstract] [Full Text]  
  • Nakamura, M., Watanabe, T., Yonekawa, Y., Kleihues, P., Ohgaki, H. (2001). Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C {->} A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis 22: 1715-1719 [Abstract] [Full Text]  
  • Zhang, Q., Ohannesian, D. W., Kreklau, E. L., Erickson, L. C. (2001). Modulation of 1,3-Bis-(2-chloroethyl)-1-nitrosourea Resistance in Human Tumor Cells Using Hammerhead Ribozymes Designed to Degrade O6-Methylguanine DNA Methyltransferase mRNA. J. Pharmacol. Exp. Ther. 298: 141-147 [Abstract] [Full Text]  
  • Costello, J. F, Plass, C. (2001). Methylation matters. J. Med. Genet. 38: 285-303 [Abstract] [Full Text]  
  • Newell-Price, J., King, P., Clark, A. J. L. (2001). The CpG Island Promoter of the Human Proopiomelanocortin Gene Is Methylated in Nonexpressing Normal Tissue and Tumors and Represses Expression. Mol. Endocrinol. 15: 338-348 [Abstract] [Full Text]  
  • Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., Herman, J. G. (2000). Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents. NEJM 343: 1350-1354 [Abstract] [Full Text]  
  • Rice, J. C., Futscher, B. W. (2000). Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res 28: 3233-3239 [Abstract] [Full Text]  
  • Rice, J. C., Ozcelik, H., Maxeiner, P., Andrulis, I., Futscher, B. W. (2000). Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21: 1761-1765 [Abstract] [Full Text]  
  • Bearzatto, A., Szadkowski, M., Macpherson, P., Jiricny, J., Karran, P. (2000). Epigenetic Regulation of the MGMT and hMSH6 DNA Repair Genes in Cells Resistant to Methylating Agents. Cancer Res. 60: 3262-3270 [Abstract] [Full Text]  
  • Müller, C., Readhead, C., Diederichs, S., Idos, G., Yang, R., Tidow, N., Serve, H., Berdel, W. E., Koeffler, H. P. (2000). Methylation of the Cyclin A1 Promoter Correlates with Gene Silencing in Somatic Cell Lines, while Tissue-Specific Expression of Cyclin A1 Is Methylation Independent. Mol. Cell. Biol. 20: 3316-3329 [Abstract] [Full Text]  
  • Esteller, M., Toyota, M., Sanchez-Cespedes, M., Capella, G., Peinado, M. A., Watkins, D. N., Issa, J.-P. J., Sidransky, D., Baylin, S. B., Herman, J. G. (2000). Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation Is Associated with G to A Mutations in K-ras in Colorectal Tumorigenesis. Cancer Res. 60: 2368-2371 [Abstract] [Full Text]  
  • Cameron, E. E., Baylin, S. B., Herman, J. G. (1999). p15INK4B CpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional Silencing. Blood 94: 2445-2451 [Abstract] [Full Text]  
  • Wong, D. J., Foster, S. A., Galloway, D. A., Reid, B. J. (1999). Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M0 Growth Arrest. Mol. Cell. Biol. 19: 5642-5651 [Abstract] [Full Text]  
  • Silber, J. R., Blank, A., Bobola, M. S., Ghatan, S., Kolstoe, D. D., Berger, M. S. (1999). O6-Methylguanine-DNA Methyltransferase-deficient Phenotype in Human Gliomas: Frequency and Time to Tumor Progression after Alkylating Agent-based Chemotherapy. Clin. Cancer Res. 5: 807-814 [Abstract] [Full Text]  
  • Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., Herman, J. G. (1999). Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation is a Common Event in Primary Human Neoplasia. Cancer Res. 59: 793-797 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»